Correlation Between Minimum Inhibitory Concentration and Clinical Outcome of Invasive Fusariosis

Completed

• Conditions: Invasive Fusariosis
• Interventions: Other: There is no intervention. This is an observational study.

• Registration Number: NCT04982159
• Lead Sponsor: Maimónides Biomedical Research Institute of Córdoba

Brief Summary

Multi-centered, international, observational and retrospective study to analyze the correlation between MIC and clinical outcome in patients with invasive fusariosis.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-01
• Primary Completion: 2020-12-31
• Study Completion: 2020-12-31
• Study First Submitted: 2021-07-06
• Study First Submitted QC: 2021-07-19
• Study First Posted: 2021-07-29
• Status Verified: 2022-05
• Last Update Submitted: 2022-05-27
• Last Update Posted: 2022-06-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

• Invasive fusariosis diagnostic
• Proof of anti-fungic susceptibility according to EUCAST or CLSI, for the medicine used in the treatment of invasive fusariosis.
• Available data about anti-fungic medicines used: name of medicine, start and end date of treatment.
• Available information about clinical outcome of illness after 30 days, 6 weeks and 90 days (dead or alive).
• Only cases of invasive fusariosis proven or possible will be included.

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Invasive Fusariosis	There is no intervention. This is an observational study.	Patients hospitalized with an invasive fusariosis diagnostic in the stablished period of study.

Primary Outcome Measures

Name	Time	Method
Clinical Evolution	6 weeks after diagnosis	Retrospective evaluation of death rate.

Trial Locations

Locations (1)

Hospital Universitario Reina Sofía; 🇪🇸 Córdoba, Spain